dalteparin and Neonatal Death studies

dalteparin and Neonatal Death

dalteparin has been researched along with Neonatal Death in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Neonatal Death: The death of a live-born INFANT less than 28 days of age.

Research Excerpts

Excerpt	Relevance	Reference
"The incidence of intrauterine growth restriction (IUGR) is estimated at about 3% of pregnancies, and it is associated with 30% of all perinatal mortality and severe morbidity with adverse neurodevelopmental and cardiovascular health consequences in adult life."	2.87	Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP). ( Camprubí, M; Figueras, F; Gomez Roig, MD; Ibáñez-Burillo, P; Masoller, N; Mazarico, E; Oros, D; Peguero, A; Rovira, C; Schoorlemmer, J; Tàssies, MD, 2018)

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Mazarico, E	1
Peguero, A	1
Camprubí, M	1
Rovira, C	1
Gomez Roig, MD	1
Oros, D	1
Ibáñez-Burillo, P	1
Schoorlemmer, J	1
Masoller, N	1
Tàssies, MD	1
Figueras, F	1

Studies

Mazarico, E

Peguero, A

Camprubí, M

Rovira, C

Gomez Roig, MD

Oros, D

Ibáñez-Burillo, P

Schoorlemmer, J

Masoller, N

Tàssies, MD

Figueras, F

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Treatment of Intrauterine Growth Restriction With Low Molecular Heparin: Randomized Clinical Trial. Tratamiento Del Crecimiento Intrauterino Restringido Precoz Con Heparina de Bajo Peso Molecular: Ensayo clínico Aleatorizado.[NCT03324139]	Phase 3	50 participants (Anticipated)	Interventional	2017-10-31	Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Treatment of Intrauterine Growth Restriction With Low Molecular Heparin: Randomized Clinical Trial. Tratamiento Del Crecimiento Intrauterino Restringido Precoz Con Heparina de Bajo Peso Molecular: Ensayo clínico Aleatorizado.[NCT03324139]

Phase 3

50 participants (Anticipated)

Interventional

2017-10-31

Not yet recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for dalteparin and Neonatal Death

Article	Year
Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP). BMJ open, 2018, 10-23, Volume: 8, Issue:10 Topics: Female; Fetal Growth Retardation; Gestational Age; Heparin, Low-Molecular-Weight; Humans; Infant, Ne	2018

Article

Year

Study protocol for a randomised controlled trial: treatment of early intrauterine growth restriction with low molecular weight heparin (TRACIP).

BMJ open, 2018, 10-23, Volume: 8, Issue:10

Topics: Female; Fetal Growth Retardation; Gestational Age; Heparin, Low-Molecular-Weight; Humans; Infant, Ne

2018